Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Malignant Lymphoma

Free Subscription 03.08.2026 1 Am J Surg Pathol 1 Blood 1 Br J Dermatol 2 Br J Haematol 1 Int J Radiat Oncol Biol Phys 1 J Clin Oncol 1 Leuk Lymphoma 3 Leukemia

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Surg Pathol

1. LOU X, Chen K, Yu M, Lei C, et al
   Sporadic Burkitt Lymphoma Lacking MYC Protein Expression: A Rare Entity With Diagnostic Pitfalls and Dismal Prognosis.
   Am J Surg Pathol. 2026 Jul 31. doi: 10.1097/PAS.0000000000002593.
   PubMed         Abstract available
   
   

   
   Blood

2. POGGIO T, Grassel L, Andrieux G, Gomez Martinez AM, et al
   CD4+ T cells orchestrate the immune response to ALK-positive T-cell lymphoma.
   Blood. 2026 Jul 28:blood.2026033240. doi: 10.1182/blood.2026033240.
   PubMed         Abstract available
   
   

   
   Br J Dermatol

3. 
   Correction to: LY21 A rare case of cutaneous CD4-positive cytotoxic T-cell lymphoma.
   Br J Dermatol. 2026 Jul 29:ljag304. doi: 10.1093.
   PubMed        
   
   

   
   Br J Haematol

4. SHIVAROV V
   Immune-related adverse events in Hodgkin lymphoma treated with pembrolizumab or nivolumab: A disease-restricted US Food and Drug Administration Adverse Event Reporting System (FAERS) pharmacovigilance analysis.
   Br J Haematol. 2026 Jul 29. doi: 10.1111/bjh.70724.
   PubMed        
   
   
5. SCHULZ E, Posch F, Friedrich K, Neumeister P, et al
   Comparison of outcomes after DA-EPOCH-R or GMALL high-intensity therapy for front-line treatment of Burkitt lymphoma: A retrospective cohort.
   Br J Haematol. 2026 Jul 25. doi: 10.1111/bjh.70730.
   PubMed         Abstract available
   
   

   
   Int J Radiat Oncol Biol Phys

6. ZHU YM, Zhou YM, Peng P, Wu YP, et al
   Prognostic and Treatment Values of Baseline Metabolic Tumor Volume in Early-stage Extranodal NK/T-cell Lymphoma in the Modern Treatment Era.
   Int J Radiat Oncol Biol Phys. 2026 Jul 29:S0360-3016(26)04079.
   PubMed         Abstract available
   
   

   
   J Clin Oncol

7. WILSON MR, Lewis KL, Kirkwood AA, Cwynarski K, et al
   Erratum: High-Dose Methotrexate as CNS Prophylaxis in Ultra High-Risk Large B-Cell Lymphoma: An International Multicenter Analysis.
   J Clin Oncol. 2026 Jul 27:JCO2601800. doi: 10.1200/JCO-26-01800.
   PubMed        
   
   

   
   Leuk Lymphoma

8. LIN Y, Palivela M, Lakzadeh P, Limbrick-Oldfield E, et al
   Systematic literature review of clinical outcomes, health-related quality of life, and healthcare costs and resource use in relapsed/refractory large B-cell lymphoma treated with axicabtagene ciloleucel.
   Leuk Lymphoma. 2026 Jul 27:1-16. doi: 10.1080/10428194.2026.2695323.
   PubMed         Abstract available
   
   

   
   Leukemia

9. D'SOUZA C, Thio N, Zhu R, DeSilva H, et al
   Breast implant associated anaplastic large cell lymphoma is a heterogeneous T cell disease with active pro-tumour cross-talk and immune suppression.
   Leukemia. 2026 Jul 30. doi: 10.1038/s41375-026-03049.
   PubMed         Abstract available
   
   
10. CHEN J, Zhu Y, Shi ZY, Li X, et al
    Tumor molecular age acceleration is associated with early progression in diffuse large B-cell lymphoma.
    Leukemia. 2026 Jul 27. doi: 10.1038/s41375-026-03076.
    PubMed        
    
    
11. BABIN L, Andraos E, Fuchs S, Bessiere C, et al
    CircZBTB46, a promising therapeutic target in crizotinib resistant ALK-positive T lymphomas.
    Leukemia. 2026;40:1735-1747.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum